Castration is the standard therapeutic treatment for advanced prostate cancer but with limited benefit due to the profound relapse and metastasis. Activation of inflammatory signaling pathway and initiation of epithelial-mesenchymal transition (EMT) are closely related to drug resistance, tumor relapseas well as metastasis. In this study, we demonstrated that metformin is capable of inhibiting prostate cancer cell migration and invasion by repressing EMT evidenced by downregulating the mesenchymal markers N-cadherin, Vimentin, and Twist and upregulating the epithelium E-cadherin.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2io92Wr
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Greens Blue Flame supplies propane tank installation services and propane delivery in the Houston, TX area. We also offer bulk commercial de...
-
Copyright © 1999-2007 by , Kai Froeb. Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free ...
-
A Vietnam War Timeline [Note: This timeline is an abbreviated version of the more detailed timeline posted on the Public Broadcasting System...
-
Cutaneous squamous cell carcinoma (cSCC) are amongst the most common cancers with metastatic potential. Specific clinical and pathological “...
-
IZE is a professional association dedicated to expanding the educational impact of zoos and aquariums worldwide, to enhance the understandin...
-
1,001 FREE cover letter examples and samples for consultants, career changers, and job hunters. The FIRST and BEST cover letters on the Inte...
-
The National Booster Club Training Council, Providing Guidance, Education, Training and Support from #AlexandrosSfakianakis via Alexandros...
-
Examples of Money Laundering Investigations - Fiscal Year 2015. The following examples of Money Laundering Investigations are written from p...
-
BibMe Free Bibliography & Citation Maker - MLA, APA, Chicago, Harvard from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inor...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου